老年多病共存患者糖尿病过度治疗与临床结局的关联:欧洲多中心辅助研究
本研究为欧洲多中心OPERAM项目的辅助研究,纳入490例≥70岁、患2型糖尿病并使用降糖药物的多病共存住院患者,按2019年内分泌学会指南定义糖尿病过度治疗。结果显示过度治疗与1年功能下降和住院率无显著关联,但与死亡率升高独立相关(HR 1.64,95%CI 1.06–2.52)。
要点
- 老年多病共存2型糖尿病患者中糖尿病过度治疗比例为34.3%。
- 过度治疗与功能下降和住院率无显著关联。
- 过度治疗与1年死亡率升高独立相关(HR 1.64)。
核心结论
- 糖尿病过度治疗与老年多病共存患者1年死亡率升高相关,但与功能下降和住院率无显著关联。
研究设计与样本
- 欧洲多中心OPERAM项目的辅助研究,纳入490例≥70岁、患2型糖尿病并使用降糖药物的多病共存住院患者,中位年龄78岁,女性占38%。
主要发现
- 168例(34.3%)存在糖尿病过度治疗。
- 过度治疗组与非过度治疗组功能下降率分别为29.3%与38.0%(P=0.088),住院率分别为107.3与125.8/100人年(P=0.115),死亡率分别为32.8与21.4/100人年(P=0.033)。
- 多变量分析中,过度治疗与功能下降和住院无显著关联(HR 0.80,95%CI 0.63–1.02),与死亡率升高独立相关(HR 1.64,95%CI 1.06–2.52)。
关键数值与推荐
- 糖尿病过度治疗依据2019年内分泌学会指南定义,采用根据患者整体健康状况个体化的HbA1c目标范围及使用高低血糖风险降糖药物。
临床怎么用
- 对老年多病共存2型糖尿病患者应评估是否存在过度治疗,尤其使用高低血糖风险药物者,需权衡降糖强度与死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes overtreatment is a frequent and severe issue in multimorbid older patients with type 2 diabetes (T2D). OBJECTIVE: This study aimed at assessing the association between diabetes overtreatment and 1-year functional decline, hospitalisation and mortality in older inpatients with multimorbidity and polypharmacy. METHODS: Ancillary study of the European multicentre OPERAM project on multimorbid patients aged ≥70 years with T2D and glucose-lowering treatment (GLT). Diabetes overtreatment was defined according to the 2019 Endocrine Society guideline using HbA1c target range individualised according to the patient's overall health status and the use of GLT with a high risk of hypoglycaemia. Multivariable regressions were used to assess the association between diabetes overtreatment and the three outcomes. RESULTS: Among the 490 patients with T2D on GLT (median age: 78 years; 38% female), 168 (34.3%) had diabetes overtreatment. In patients with diabetes overtreatment as compared with those not overtreated, there was no difference in functional decline (29.3% vs 38.0%, P = 0.088) nor hospitalisation rates (107.3 vs 125.8/100 p-y, P = 0.115) but there was a higher mortality rate (32.8 vs 21.4/100 p-y, P = 0.033). In multivariable analyses, diabetes overtreatment was not associated with functional decline nor hospitalisation (hazard ratio, HR [95%CI]: 0.80 [0.63; 1.02]) but was associated with a higher mortality rate (HR [95%CI]: 1.64 [1.06; 2.52]). CONCLUSIONS: Diabetes overtreatment was associated with a higher mortality rate but not with hospitalisation or functional decline. Interventional studies should be undertaken to test the effect of de-intensifying GLT on clinical outcomes in overtreated patients.
引用
- Christiaens A, Baretella O, Del Giovane C, et al. Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study. Age Ageing. 2023. PMID: 36626323. doi:10.1093/ageing/afac320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。